Oral Nadolol for the Treatment of Infantile Hemangiomas: A Single‐Institution Retrospective Cohort Study

ConclusionsOral nadolol is efficacious in patients with problematic IHs. Further large‐scale prospective comparative studies are warranted to compare nadolol with other beta‐blockers.

Source: Pediatric Dermatology - July 27, 2015 Category: Dermatology Authors: Harkamal Kaur Randhawa, Cathryn Sibbald, Maria Teresa Garcia Romero, Elena Pope Tags: Original Article Source Type: research